Background Decision coaching is non‐directive support delivered by a healthcare provider
to help patients prepare to actively participate in making a health decision.'Healthcare …

The combination of increased referral for genetic testing and the current shortage of genetic
counselors has necessitated the development and implementation of alternative models of …

Background The cost-effectiveness of population-based panel testing for high-and moderate-
penetrance ovarian cancer (OC)/breast cancer (BC) gene mutations is unknown. We …

Importance Moving to multigene testing for all women with breast cancer (BC) could identify
many more mutation carriers who can benefit from precision prevention. However, the cost …

Clinical criteria/Family history-based BRCA testing misses a large proportion of BRCA
carriers who can benefit from screening/prevention. We estimate the cost-effectiveness of …

Objective Unselected population‐based BRCA testing provides the opportunity to apply
genomics on a population‐scale to maximise primary prevention for breast‐and‐ovarian …

Abstract An estimated 2–5% of endometrial cancers and 15–20% of high-grade, non-
mucinous epithelial ovarian cancers have an underlying hereditary cause. Appropriate risk …

Background Population-based BRCA1/BRCA2 testing has been found to be cost-effective
compared with family history–based testing in Ashkenazi-Jewish women were> 30 years old …

Prognosis is generally poor for patients with pancreatic ductal adenocarcinoma. However,
patients with germline BRCA1 or BRCA2 mutations (gBRCAm) may benefit from first-line …

Background BRCA carrier identification offers opportunities for early diagnoses, targeted
treatment and cancer prevention. We evaluate BRCA-carrier detection rates in general and …